The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCI
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 3,000
- 试验地点
- 2
- 主要终点
- Combined endpoint defined by the time from intervention to either fatal og non-fatal stroke/TIA
研究概览
简要总结
The primary objective is to evaluate if patent foramen ovale (PFO) closure and antiplatelet medical management can reduce the risk of recurrent stroke or transient ischemic attack (TIA) when compared to antiplatelet medical management alone in elderly patients above 50 years of age with a PFO and a history of cryptogenic stroke or TIA.
详细描述
Prior to birth the fetal heart has a connection between the two atrias of the heart. After labour this connection often closes. About 10-15 % these connections remains open. This phenomenon is called patent foramen ovale or PFO, and is in most cases unsymptomatic.
The prevalence of PFO in patients with crytogenic (without known causes) stroke is much higher (about 40%)than the general population (about 10%). This has led to the theory that the presence of PFO can lead to stroke, by the passage of emboli from the peripheral venous circulation through the PFO to the brain by right-to-left shunting of the blood.
There are no existing data from prospective randomized studies focusing on the effect of device closure PFO in patients with cryptogenic stroke. Some observational retrospective studies have shown a beneficial effect in the reduction of recurrent stoke in patients younger that 50 years with cryptogenic stroke when PFO has been closed with a percutaneous device closure(PCD). Some studies have reported an 0% to 3.4% annual recurrence rate of stroke or TIA in patients treated with PDC. The recurrence rate of stroke or TIA in patients with crytogenic stroke or TIA in ordinary antithrombotic treatment is about 5-15 %.
The primary objective of this study is to assess whether percutaneous device closure of patent foramen ovale is superior to conventional antithrombotic treatment in preventing stroke recurrence in elderly patients above 50 years of age.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 51 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Stroke or TIA within 30 days
- •Above 50 years of age
排除标准
- •Deceases og the esophagus
- •Allergy to aspirin
- •Risk of non-compliance
- •Lacking ability to give written or oral consent
- •Atrial Fibrillation
- •Neurological deficit lasting less than 6 hours
结局指标
主要结局
Combined endpoint defined by the time from intervention to either fatal og non-fatal stroke/TIA
时间窗: Endpoints assessed every half year starting 1 year after intervention
次要结局
- Examination of residual cardiac right to left shunt after device closure of PFO(1 month after intervention)
- ct-verified stroke 2 years after intervention(2 years after intervention)
- Death by other causes than Stroke(Endpoint assessed every half year starting 1 year after intervention)
- Complications to device closure of PFO(few days after intervention)